Literature DB >> 2496144

A gamma methionine-310 to threonine substitution and consequent N-glycosylation at gamma asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi.

K Yamazumi1, K Shimura, S Terukina, N Takahashi, M Matsuda.   

Abstract

In an abnormal fibrinogen with severely impaired polymerization of fibrin monomers, we identified a methionine-to-threonine substitution at position 310 of the gamma chain. Furthermore, asparagine at position 308 was found to be N-glycosylated due to a newly formed consensus sequence, asparagine(308)-glycine(309)-threonine(310). The two structural defects in the mutant gamma chain may well perturb the conformation required for fibrin monomer polymerization that is specifically assigned to the D domain of fibrinogen. This alteration also seems to affect the intermolecular gamma chain cross-linking of fibrin and fibrinogen, although the amine acceptor gamma glutamine-398 was found to function normally. These functional abnormalities may well be related to posttraumatic hemorrhage as observed in a 33-yr-old man with moderate hemorrhagic diathesis related to injuries since his early adolescence. The structure of the extra carbohydrate moiety attached to asparagine-308 was found to be identical with those derived from the normal B beta and gamma chains as evidenced by HPLC.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496144      PMCID: PMC303865          DOI: 10.1172/JCI114056

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Studies on the structural abnormality of fibrinogen Paris I.

Authors:  M W Mosesson; D L Amrani; D Ménaché
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

2.  Enzyme-linked coagulation assay. III. Sensitive immunoassays for clotting factors II, VII, and X.

Authors:  G J Doellgast
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization.

Authors:  V J Marder; N R Shulman; W R Carroll
Journal:  J Biol Chem       Date:  1969-04-25       Impact factor: 5.157

4.  Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.

Authors:  M L Schwartz; S V Pizzo; R L Hill; P A McKee
Journal:  J Biol Chem       Date:  1973-02-25       Impact factor: 5.157

5.  - cross-linking sites in human and bovine fibrin.

Authors:  R Chen; R F Doolittle
Journal:  Biochemistry       Date:  1971-11-23       Impact factor: 3.162

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Characterization of a complementary deoxyribonucleic acid coding for the gamma chain of human fibrinogen.

Authors:  D W Chung; W Y Chan; E W Davie
Journal:  Biochemistry       Date:  1983-06-21       Impact factor: 3.162

8.  Evidence for four different polymerization sites involved in human fibrin formation.

Authors:  S A Olexa; A Z Budzynski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.

Authors:  H R Gralnick; H M Givelber; J R Shainoff; J S Finlayson
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

10.  Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.

Authors:  N Yoshida; S Terukina; M Okuma; M Moroi; N Aoki; M Matsuda
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

View more
  9 in total

1.  Fibrinogen Tokushima II: a new case of congenital dysfibrinogenemia with a γ methionine-310 to threonine substitution.

Authors:  Toshio Shigekiyo; Etsuko Sekimoto; Atsuhisa Shirakami; Hiroshi Yamaguchi; Hironobu Shibata; Shuji Ozaki; Masahiko Maegawa; Ken-ichi Aihara
Journal:  Int J Hematol       Date:  2012-07-27       Impact factor: 2.490

2.  Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site.

Authors:  R B Parad; J Kramer; R C Strunk; F S Rosen; A E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 3.  Structure and function of human fibrinogen inferred from dysfibrinogens.

Authors:  Michio Matsuda; Teruko Sugo
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

4.  Fibrinogen Lima: a homozygous dysfibrinogen with an A alpha-arginine-141 to serine substitution associated with extra N-glycosylation at A alpha-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator.

Authors:  H Maekawa; K Yamazumi; S Muramatsu; M Kaneko; H Hirata; N Takahashi; C L Arocha-Piñango; S Rodriguez; H Nagy; J L Perez-Requejo
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

5.  Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones.

Authors:  Wing C Lee; Dongcheul Kang; Ena Causevic; Aimee R Herdt; Elizabeth A Eckman; Christopher B Eckman
Journal:  J Neurosci       Date:  2010-04-21       Impact factor: 6.167

6.  Fibrinogen Osaka IV: a congenital dysfibrinogenemia found in a patient originally reported in relation to surgery, now defined to have an A alpha arginine-16 to histidine substitution.

Authors:  K Yamazumi; S Terukina; M Matsuda; J Kanbayashi; M Sakon; T Tsujinaka
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 7.  Structural changes of proteins in liver cirrhosis and consequential changes in their function.

Authors:  Nikola Gligorijević; Simeon Minić; Olgica Nedić
Journal:  World J Gastroenterol       Date:  2022-08-07       Impact factor: 5.374

8.  Fibrinogen Yecheon: congenital dysfibrinogenemia with gamma methionine-310 to threonine substitution.

Authors:  Eunkyung Park; Geumbore Park; Rojin Park; Hee-Jin Kim; Sang Jae Lee; Young Joo Cha
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

Review 9.  Human plasma protein N-glycosylation.

Authors:  Florent Clerc; Karli R Reiding; Bas C Jansen; Guinevere S M Kammeijer; Albert Bondt; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2015-11-10       Impact factor: 2.916

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.